THIS IS WHAT HE HAD TO SAY.
Quote:
--------------------------------------------------------------------------------
We have no idea why our stock is under such a large amount of pressure lately and can only speculate as to the cause. Like yourself we find it very frustrating, particularly as nothing at all has changed at YM to cause this. We remain enthusiastic for the prospects of our lead drug CYT387, for which we will present updated data at the ASH conference on Dec 12.
Regards,
James
--------------------------------------------------------------------------------
James Smith, M.Sc.(Eng)
VP Corporate Communications
YM BioSciences Inc.
5045 Orbitor Drive
Building 11, Suite 400
Mississauga, Ontario L4W 4Y4
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM